Medicus Pharma (MDCX) Invested Capital (2023 - 2025)

Medicus Pharma (MDCX) has reported Invested Capital for 3 consecutive years, with $5.2 million the latest figure, recorded in Q4 2025.

• Invested Capital for Q4 2025 came in at $5.2 million, up 65.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.2 million (up 65.18% YoY), and the FY2025 annual result was $5.2 million, up 65.18% from the prior year.
• Invested Capital was $5.2 million for Q4 2025 at Medicus Pharma, down from $5.9 million in the prior quarter.
• Over five years, Invested Capital peaked at $7.9 million in Q2 2025 and troughed at -$559957.0 in Q1 2024.
• Average Invested Capital over 3 years is $4.1 million, with a median of $4.8 million recorded in 2024.
• The widest YoY moves for Invested Capital: up 483.52% in 2025, down 12.37% in 2025.
• Over 3 years, Invested Capital stood at $1.1 million in 2023, then jumped by 182.04% to $3.1 million in 2024, then soared by 65.18% to $5.2 million in 2025.
• Per Business Quant data, the three most recent Invested Capital figures were $5.2 million in Q4 2025, $5.9 million in Q3 2025, and $7.9 million in Q2 2025.